Reglagene
PrivateLast Round
Series A
Dec 19, 2023
Total Funding Raised
$5.85M
Momentum Score
50 /100
Company Overview
Reglagene is a therapeutics company that develops brain-penetrant medicines for the treatment of brain diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reglagene Comps
Public and private peers based on sector, stage, and business model.
Reglagene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 19, 2023 | ||||
| Grant | Mar 9, 2020 | ||||
| Grant | Sep 1, 2018 |
Reglagene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Tech Coast Angels | Series A |
| Viva BioInnovator | Series A |
| Arizona Commerce Authority | Grant |
| Desert Angels | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 37% MoM.
- Apr 22, 2025
Received the Outstanding Client Award at InBIA's 39th Annual Conference.
Reglagene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reglagene's valuation, stock price, and market status.
